The Biden administration’s ‘multilateralism’ could make ‘America First’ look positively magnanimous
By Ross Clark
The report does not even claim to be independent
By Ross Clark
The British shot cuts the risk of developing symptomatic infection by 79 percent
By Ross Clark
This administration’s financial philosophy seems to be ‘let’s pour rocket fuel on the flames’
By Ross Clark
Some will be able to get out in time, but most won’t
By Ross Clark
A new study examines the behavior of the immune system in the months after COVID exposure
By Ross Clark
All the participants who received the half dose followed by a full dose were under 55
By Ross Clark
If one vaccine provides immunity lasting months and another years, the relative costs of each could shift dramatically
By Ross Clark
Over 50 million cases of COVID-19 have now been recorded globally — and yet only a handful of cases of reinfection have been documented
By Ross Clark
A new paper looks at the possibility that SARS-CoV-2 was artificially created
By Ross Clark
The company can provisionally claim that their vaccine is 94.5 percent effective
By Ross Clark
The estimated number of deaths globally from measles climbed to 207,500 in 2019
By Ross Clark
Any vaccine that proves partly effective will be welcomed with open arms by a world which largely remains in lockdown or semi-lockdown
By Ross Clark
